The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices

Ying Chen,Thomas J.W. Sharples,Keith G. Phillips,Giovanni Benedetti,Lisa M. Broad,Ruud Zwart,Emanuele Sher

DOI: https://doi.org/10.1016/S0028-3908(03)00189-8

IF: 5.273

2003-01-01

Neuropharmacology

Abstract:The ability of α4β2 nicotinic acetylcholine receptors to modulate dopaminergic (DA) cell activity in the ventral tegmental area (VTA) in rat midbrain slices was assessed using a selective α4β2 receptor agonist, TC-2559 ((E)-N-methyl-4-[3-(5-ethoxypyridin)y1]-3-buten-1-amine). The selectivity of TC-2559 was characterized across 6 recombinant human nicotinic receptors (α4β2, α2β4, α4β4, α3β4, α3β2 and α7) stably expressed in mammalian cell lines. Using a fluorescent imaging plate reader and fluo-3 to monitor changes in intracellular calcium, TC-2559 was found to be at least 69 fold more potent on α4β2 than on other heteromeric subtypes, with an efficacy of 33%. No activity on the homomeric α7 subtype was detected. TC-2559 also showed selectivity for α4β2 over the α4β4 and α7 subtypes expressed in Xenopus oocytes. When bath applied to VTA slices, TC-2559 increased the firing of DA cells in a dose-dependent manner, in the same concentration range that activates α4β2 receptors in recombinant cell lines or oocytes. The effect of TC-2559 was blocked by 2 μM dihydro-β-erythroidine (an α4β2-preferring antagonist), but not by 10 nM methyllycaconitine (an α7 antagonist). Glutamate receptor antagonists (6-cyano-7-nitroquinoxaline-2,3-dione and D(−)-2-amino-5-phosphonopentanoic acid) did not reduce TC-2559-induced responses, suggesting that the increase in DA cell firing induced by TC-2559 is caused by direct postsynaptic depolarisation via the activation of α4β2 receptors and not by enhancement of glutamate release.